NM_001849.4:c.-27-89G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001849.4(COL6A2):​c.-27-89G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00517 in 713,700 control chromosomes in the GnomAD database, including 77 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.015 ( 53 hom., cov: 31)
Exomes 𝑓: 0.0024 ( 24 hom. )

Consequence

COL6A2
NM_001849.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -3.77

Publications

0 publications found
Variant links:
Genes affected
COL6A2 (HGNC:2212): (collagen type VI alpha 2 chain) This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]
COL6A2 Gene-Disease associations (from GenCC):
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Ullrich congenital muscular dystrophy 1B
    Inheritance: AR, AD Classification: DEFINITIVE Submitted by: G2P
  • Bethlem myopathy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myosclerosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 21-46111361-G-A is Benign according to our data. Variant chr21-46111361-G-A is described in ClinVar as [Benign]. Clinvar id is 679820.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0152 (2321/152314) while in subpopulation AFR AF = 0.0499 (2074/41572). AF 95% confidence interval is 0.0481. There are 53 homozygotes in GnomAd4. There are 1113 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 53 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A2NM_001849.4 linkc.-27-89G>A intron_variant Intron 1 of 27 ENST00000300527.9 NP_001840.3 P12110-1A0A384MDP3
LOC124905043XR_007067910.1 linkn.671C>T non_coding_transcript_exon_variant Exon 1 of 2
COL6A2NM_058174.3 linkc.-27-89G>A intron_variant Intron 1 of 27 NP_478054.2 P12110-2
COL6A2NM_058175.3 linkc.-27-89G>A intron_variant Intron 1 of 27 NP_478055.2 P12110-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A2ENST00000300527.9 linkc.-27-89G>A intron_variant Intron 1 of 27 1 NM_001849.4 ENSP00000300527.4 P12110-1
COL6A2ENST00000397763.6 linkc.-27-89G>A intron_variant Intron 1 of 27 5 ENSP00000380870.1 P12110-2
COL6A2ENST00000436769.5 linkc.-27-89G>A intron_variant Intron 1 of 2 2 ENSP00000390418.1 C9JH44
COL6A2ENST00000409416.6 linkc.-116G>A upstream_gene_variant 5 ENSP00000387115.1 P12110-3

Frequencies

GnomAD3 genomes
AF:
0.0152
AC:
2318
AN:
152196
Hom.:
53
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0499
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00955
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00868
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000412
Gnomad OTH
AF:
0.0124
GnomAD4 exome
AF:
0.00244
AC:
1369
AN:
561386
Hom.:
24
AF XY:
0.00208
AC XY:
613
AN XY:
295350
show subpopulations
African (AFR)
AF:
0.0469
AC:
738
AN:
15746
American (AMR)
AF:
0.00426
AC:
130
AN:
30500
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
17042
East Asian (EAS)
AF:
0.00536
AC:
170
AN:
31726
South Asian (SAS)
AF:
0.000371
AC:
21
AN:
56574
European-Finnish (FIN)
AF:
0.0000254
AC:
1
AN:
39328
Middle Eastern (MID)
AF:
0.00381
AC:
9
AN:
2360
European-Non Finnish (NFE)
AF:
0.000387
AC:
131
AN:
338324
Other (OTH)
AF:
0.00567
AC:
169
AN:
29786
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.518
Heterozygous variant carriers
0
61
122
183
244
305
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0152
AC:
2321
AN:
152314
Hom.:
53
Cov.:
31
AF XY:
0.0149
AC XY:
1113
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.0499
AC:
2074
AN:
41572
American (AMR)
AF:
0.00954
AC:
146
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00850
AC:
44
AN:
5174
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000412
AC:
28
AN:
68028
Other (OTH)
AF:
0.0123
AC:
26
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
117
233
350
466
583
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0145
Hom.:
3
Bravo
AF:
0.0180
Asia WGS
AF:
0.00289
AC:
10
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.44
DANN
Benign
0.62
PhyloP100
-3.8
PromoterAI
0.0072
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115342490; hg19: chr21-47531275; COSMIC: COSV100153131; COSMIC: COSV100153131; API